KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
Yulin Lin(Centers for Disease Control and Prevention), Ann‐Lii Cheng(National Taiwan University)
Cited by 48
Related Papers
Validation of the ITS2 Region as a Novel DNA Barcode for Identifying Medicinal Plant Species
|PLoS ONE|2010|1.7k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775